<VariationArchive RecordType="classified" VariationID="1071696" VariationName="NC_000015.9:g.(?_80473374)_(80478561_?)del" VariationType="Deletion" Accession="VCV001071696" Version="4" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-11" DateCreated="2021-05-10" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1057715" VariationID="1071696">
      <GeneList>
        <Gene Symbol="FAH" FullName="fumarylacetoacetate hydrolase" GeneID="2184" HGNC_ID="HGNC:3579" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="80152789" stop="80186949" display_start="80152789" display_stop="80186949" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="80445232" stop="80478923" display_start="80445232" display_stop="80478923" Strand="+" />
          </Location>
          <OMIM>613871</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000015.9:g.(?_80473374)_(80478561_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" innerStart="80473374" innerStop="80478561" display_start="80473374" display_stop="80478561" variantLength="5188" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.(?_80473374)_(80478561_?)del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.(?_80473374)_(80478561_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000015.9:g.(?_80473374)_(80478561_?)del AND Tyrosinemia type I" Accession="RCV001384218" Version="4">
        <ClassifiedConditionList TraitSetID="6267">
          <ClassifiedCondition DB="MedGen" ID="C0268490">Tyrosinemia type I</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-09-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6267" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15974" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tyrosinemia type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tyrosinemia type I</ElementValue>
                <XRef ID="Tyrosinemia+type+1/7281" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010161" DB="MONDO" />
                <XRef ID="410056006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatorenal tyrosinemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fumarylacetoacetase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FAH deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deficiency of fumarylacetoacetase</ElementValue>
                <XRef ID="124536006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TYRSN1</ElementValue>
                <XRef Type="MIM" ID="276700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Untreated tyrosinemia type I usually presents either in young infants with severe liver involvement or later in the first year with liver dysfunction and renal tubular dysfunction associated with growth failure and rickets. Untreated children may have repeated, often unrecognized, neurologic crises lasting one to seven days that can include change in mental status, abdominal pain, peripheral neuropathy, and/or respiratory failure requiring mechanical ventilation. Death in the untreated child usually occurs before age ten years, typically from liver failure, neurologic crisis, or hepatocellular carcinoma. Combined treatment with nitisinone and a low-tyrosine diet has resulted in a greater than 90% survival rate, normal growth, improved liver function, prevention of cirrhosis, correction of renal tubular acidosis, and improvement in secondary rickets.</Attribute>
                <XRef ID="NBK1515" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000568295" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000264964" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2658" />
                <XRef ID="2658" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301688</ID>
                <ID Source="BookShelf">NBK1515</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Increased Tyrosine, Tyrosinemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tryosine-Elevated-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Elevated, Succinylacetone Normal, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Tyrosine-Normal-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Tyrosine Normal/Elevated, Succinylacetone Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="882" DB="Orphanet" />
              <XRef ID="C0268490" DB="MedGen" />
              <XRef ID="MONDO:0010161" DB="MONDO" />
              <XRef Type="MIM" ID="276700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3109253" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_000137.2_15_Deletion (exons 13-14)|MedGen:C0268490" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583613" DateUpdated="2023-11-11" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 13-14 of the FAH gene. The 5' boundary is likely confined to intron 12. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with FAH-related conditions. This variant disrupts a region of the FAH protein in which other variant(s) (p.Tyr401*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000015.9:g.(?_80473374)_(80478561_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268490" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3109253" TraitType="Disease" MappingType="XRef" MappingValue="C0268490" MappingRef="MedGen">
        <MedGen CUI="C0268490" Name="Tyrosinemia type I" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

